Search results for "Vaccination strategy"

showing 2 items of 2 documents

Cost analysis of a vaccination strategy for respiratory syncytial virus (RSV) in a network model

2010

[EN] In this paper an age-structured mathematical model for respiratory syncytial virus (RSV) is proposed where children younger than one year old, who are the most affected by this illness, are specially considered. Real data of hospitalized children in the Spanish region of Valencia are used in order to determine some seasonal parameters of the model. Once the parameters are determined, we propose a complete stochastic network model to study the seasonal evolution of the respiratory syncytial virus (RSV) epidemics. In this model every susceptible individual can acquire the disease after a random encounter with any infected individual in the social network. The edges of a complete graph co…

Cost estimationbusiness.industryStochastic modellingDiseaseBiologyRespiratory syncytial virusmedicine.disease_causeVaccination strategyComputer Science ApplicationsVaccinationRespiratory syncytial virus (RSV)Network mathematical modelSusceptible individualModeling and SimulationModelling and SimulationStatisticsmedicineCost analysisProbability distributionArtificial intelligencebusinessMATEMATICA APLICADANetwork modelMathematical and Computer Modelling
researchProduct

Age- and Sex-Graded Data Evaluation of Vaccination Reactions after Initial Injection of the BNT162b2 mRNA Vaccine in a Local Vaccination Center in Ge…

2021

A high vaccination rate of older and particularly chronically ill people against coronavirus disease-2019 (COVID-19) is likely one of the most important factors in containing the pandemic. When Germany’s vaccination campaign started on December 2020, vaccination prioritization was initially carried out starting with older population groups. Side effect rates in 1065 individuals who had received the first dose of the messenger ribonucleic acid (mRNA) vaccine BNT162b2 Tozinameran from BioNTech/Pfizer three weeks earlier were examined retrospectively. An age- and gender-graded data analysis showed clear age and gender differences with regard to vaccine-related adverse effects. In 77% of all in…

Pediatricsmedicine.medical_specialtySide effectCoronavirus disease 2019 (COVID-19)COVID-19 vaccinationImmunologyage- and sex-graded data evaluationArticleHerd immunityImmunityDrug DiscoveryPandemicmedicinePharmacology (medical)Adverse effectPharmacologyvaccination strategymRNA vaccine BNT162b2business.industryRVaccinationInfectious DiseasesPopulation studyMedicinebusinessvaccination side effectsVaccines
researchProduct